Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. - Wikidata - awgldk - TriplyDB

Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.

Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.

http://www.wikidata.org/entity/Q37218835

about

'Big things in small packages: the genetics of filamentous phage and effects on fitness of their host'Role of bacteriophages in STEC infections: new implications for the design of prophylactic and treatment approaches Bacteriophages as pathogens and immune modulators?

P2860

Q28086818-D7DA4AB8-8580-44E7-A85B-B9C469F70A72 Q34885883-BB6F73DA-F0A9-444C-B77C-6D58948141C3 Q37408432-F69E2C00-E7A5-4393-8E4E-3220CB05DC2A

P2860

Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.

http://www.wikidata.org/entity/Q37218835

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Promoter sequence of Shiga tox ...... n of biologically active Stx2.

@en

Promoter sequence of Shiga tox ...... n of biologically active Stx2.

@nl

type

label

Promoter sequence of Shiga tox ...... n of biologically active Stx2.

@en

Promoter sequence of Shiga tox ...... n of biologically active Stx2.

@nl

prefLabel

Promoter sequence of Shiga tox ...... n of biologically active Stx2.

@en

Promoter sequence of Shiga tox ...... n of biologically active Stx2.

@nl

P1433

Q37218835-60796391-3366-42B0-882A-6BA4CC04A60A

P1476

Q37218835-F10F8FDC-4C17-4DE7-A79B-3CC2775B00AF

P2093

Q37218835-01B77A52-2A78-437A-80EE-419EFF7A7798

Q37218835-063B6A90-7010-4730-B9E8-85312E091303

Q37218835-37196683-98CF-4EE8-9E6A-AEB4E37374A5

Q37218835-3E901579-C3F1-4EAD-8586-57E557D9533A

Q37218835-417592A5-0B6B-4E5E-A44E-3893D842028C

Q37218835-866A4D1F-B57E-4F06-A9D3-07578DEEF922

Q37218835-9468E41D-DE1D-46C6-AE7C-37658C56C9F4

Q37218835-9ADD887B-6C18-4E0A-A257-C7D182ED11E8

Q37218835-C409604D-10D3-49C5-82C7-2BB8D6545A0F

Q37218835-FE5A83AF-A151-4001-BCF5-113F27BF5525

P2860

Q37218835-0286AEBE-96E3-4ECC-AC06-91928516129A

Q37218835-0DA10F90-2A3D-4EB2-B626-E7C5742689EC

Q37218835-16B31E69-4A2B-4868-BD84-D2C157E51242

Q37218835-18407677-C822-42A1-9EF9-CB4B38464DD2

Q37218835-18690150-1FEB-439D-BC0D-398B0E49D029

Q37218835-1B93F60B-0892-4AAB-B067-6414ED3D87B9

Q37218835-28E99D9A-F725-4C27-A59E-2F2AF1D0574D

Q37218835-2F079781-06C0-4074-911E-50D7A87C5004

Q37218835-33DD7EB2-F3DE-4313-A249-6545167287B1

Q37218835-34C11E38-6589-426F-A1DF-99618E1CA2EB

P304

Q37218835-A700C5DA-2804-4903-9FD0-67487A4BA037

P31

Q37218835-0DF35D04-F34C-47F2-8FFC-89FF4D2D6F44

P356

Q37218835-61C96235-4918-4562-9E6C-8676AEDB1FA0

P433

Q37218835-7A9CF0DC-75AB-448A-896F-68930F2DE8B8

P478

Q37218835-9E2F2D40-6313-4B83-99B3-5DE589F94DD4

P50

Q37218835-DD7DBEFF-A38E-422F-BBA2-AD0A185946A5

P577

Q37218835-E0B3AB51-A3F5-45C8-8FB1-8542A47CAD84

P698

Q37218835-1BE7A9C4-9A05-444E-BB57-A499AD9DFB9B

P932

Q37218835-3E480AEC-9889-4458-8F97-F09C2E7B7947

P356

P1433

P1476

Promoter sequence of Shiga tox ...... n of biologically active Stx2.

@en

P2093

Alípio Pinto

http://www.w3.org/2001/XMLSchema#string

Jorge Goldstein

http://www.w3.org/2001/XMLSchema#string

Leticia V Bentancor

http://www.w3.org/2001/XMLSchema#string

Luciano P Pedrotti

http://www.w3.org/2001/XMLSchema#string

Marcos F Bilen

http://www.w3.org/2001/XMLSchema#string

Maria C Rodriguez-Galán

http://www.w3.org/2001/XMLSchema#string

Maria P Mejías

http://www.w3.org/2001/XMLSchema#string

Marina S Palermo

http://www.w3.org/2001/XMLSchema#string

Natalia Baez

http://www.w3.org/2001/XMLSchema#string

Roberto Meiss

http://www.w3.org/2001/XMLSchema#string

P2860

Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response

Pathogenic Escherichia coli

Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note.

Acute neurology and neurophysiology of haemolytic-uraemic syndrome

Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.

Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.

Infection by Shiga toxin-producing Escherichia coli: an overview.

Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma.

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.

P304

e00501-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MBIO.00501-13

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Pablo Daniel Ghiringhelli

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24085779

http://www.w3.org/2001/XMLSchema#string

P932

3791892

http://www.w3.org/2001/XMLSchema#string